Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National Tissue Freezing Protocol is Essential for Modern Cancer Care and Research.

Trends in medicine·2026
Same author

The role of proteomics and radioproteomics in biomarkers of liver HCC for diagnosis, therapy and enhance interventional radiological treatments.

Cancer reports and reviews·2025
Same author

Comparison of LIRADS 5 Image Guided Core Biopsy Derived From Formalin Fixed and Frozen Tissue Cores for Radiogenomics and Radioproteomics Analysis in Well, Moderate and Poorly Differentiated Hepatocellular Carcinoma.

Global medicine and therapeutics·2024
Same author

Proteomics identification of radiation-induced changes of membrane proteins in the rat model of arteriovenous malformation in pursuit of targets for brain AVM molecular therapy.

Clinical proteomics·2019
Same author

Integral membrane proteins: bottom-up, top-down and structural proteomics.

Expert review of proteomics·2017
Same author

Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies.

Clinical proteomics·2017

Related Experiment Video

Updated: Oct 7, 2025

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

406

Proteogenomics for pediatric brain cancer.

Margaret Simonian1

  • 1University of Californian Los Angeles, David Geffen School of Medicine, Los Angeles, 90095, USA.

Biocell : Official Journal of the Sociedades Latinoamericanas De Microscopia Electronica ... Et. Al
|January 10, 2022
PubMed
Summary

Proteogenomics analysis reveals key biological drivers in pediatric central nervous system tumors. This approach aids in discovering diagnostic biomarkers and potential therapeutic targets for childhood brain cancers.

Keywords:
Brain cancerProteogenomicsTargeted therapy

More Related Videos

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.9K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K

Related Experiment Videos

Last Updated: Oct 7, 2025

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Published on: May 2, 2025

406
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.9K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.1K

Area of Science:

  • Oncology
  • Genomics
  • Proteomics
  • Transcriptomics

Background:

  • Pediatric central nervous system tumors represent a significant portion of childhood malignancies and are a leading cause of cancer-related mortality.
  • Proteogenomics, integrating proteomics, genomics, and transcriptomics, offers a powerful approach for biomarker discovery and therapeutic target identification.

Purpose of the Study:

  • To apply integrative proteogenomics to pediatric tumors for a deeper understanding of tumorigenesis.
  • To identify novel biomarkers for diagnosis and potential therapeutic strategies in pediatric cancers.

Main Methods:

  • Utilized an integrative proteogenomics approach combining proteomic, genomic, and transcriptomic data.
  • Analyzed pediatric tumor samples to identify underlying biological processes and genetic alterations.

Main Results:

  • The study identified critical biological processes driving pediatric tumor development.
  • Functional effects of somatic mutations and copy number variations contributing to tumorigenesis were elucidated.
  • Potential diagnostic biomarkers and therapeutic targets were discovered.

Conclusions:

  • Integrative proteogenomics is effective in unraveling the complexities of pediatric central nervous system tumors.
  • This approach holds promise for advancing the diagnosis and treatment of childhood brain cancers.